Verthermia Selects Merge eClinicalOS® for Whole Body Hyperthermia Ovarian Cancer Treatment Trial

By November 6, 2014Press Release

Verthermia, Inc. has selected the eClinicalOS data management platform from Merge eClinical for its clinical trial exploring the potential of whole body hyperthermia as a standalone treatment for women with Stage III or IV ovarian cancer. For more information, read Merge’s press release.